Brain cancer breakthrough? immune cell therapy shows promise in phase 3 trial
Disease control
Completed
This study tested whether adding an immune cell therapy called Immuncell-LC to standard chemotherapy (temozolomide) helps people with newly diagnosed glioblastoma, an aggressive brain cancer. 180 adults in Korea participated. The goal was to see if the combination slowed cancer g…
Phase: PHASE3 • Sponsor: GC Cell Corporation • Aim: Disease control
Last updated Jun 17, 2026 00:45 UTC